-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
-
Summary
-
InMed Pharmaceuticals Inc. quarterly/annual Return On Equity history and growth rate from Q2 2020 to Q2 2025.
- InMed Pharmaceuticals Inc. Return On Equity for the quarter ending June 30, 2025 was -93.2 %, a 28.7% increase year-over-year.
- InMed Pharmaceuticals Inc. annual Return On Equity for 2025 was -93.2 %, a 28.7% increase from 2024.
- InMed Pharmaceuticals Inc. annual Return On Equity for 2024 was -131 %, a 105% decline from 2023.
- InMed Pharmaceuticals Inc. annual Return On Equity for 2023 was -63.8 %, a 57.7% increase from 2022.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)